HIV/HCV-coinfection: which role can new antiretrovirals such as integrase inhibitors play?

End-stage liver disease has become one of the most frequent causes of death in HIV/HCV-coinfected patients. The role of new antiretrovirals in the progression of liver fibrosis has yet to be defined. However with significant toxicities and drug-to-drug interactions of nucleoside reverse transcriptas...

Descripción completa

Detalles Bibliográficos
Autores principales: Vogel, Martin, Nelson, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3516823/
https://www.ncbi.nlm.nih.gov/pubmed/19959415
http://dx.doi.org/10.1186/2047-783X-14-S3-36

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3516823/
https://www.ncbi.nlm.nih.gov/pubmed/19959415
http://dx.doi.org/10.1186/2047-783X-14-S3-36

Ejemplares similares